Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Cameron

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Molecular Biotechnology|June 1, 1997
Recent advances in transgenic technologyE R Cameron
Trends in Microbiology|March 1, 1997
p53 and tumour viruses: catching the guardian off-guardJ C Neil, E R Cameron, E W Baxter
The British Veterinary Journal|January 1, 1994
Transgenic scienceE R Cameron, M J Harvey, D E Onions
British Journal of Cancer|January 1, 1997
Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?G Webster, D E Onions, J C Neil, et al.
Journal of Virology|September 18, 2001
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic miceE W Baxter, K Blyth, E R Cameron, et al.
Oncogene|December 22, 1999
A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with mycF Vaillant, K Blyth, A Terry, et al.
Oncogene|March 4, 2000
Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER miceK Blyth, M Stewart, M Bell, et al.
The Journal of Pathology|January 30, 1999
Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expressionA P Hall, J Irvine, K Blyth, et al.
Journal of Virology|April 1, 1996
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?E W Baxter, K Blyth, L A Donehower, et al.
Oncogene|April 21, 2001
Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral taggingK Blyth, A Terry, N Mackay, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Biotechnology|June 1, 1997
Recent advances in transgenic technologyE R Cameron
Trends in Microbiology|March 1, 1997
p53 and tumour viruses: catching the guardian off-guardJ C Neil, E R Cameron, E W Baxter
The British Veterinary Journal|January 1, 1994
Transgenic scienceE R Cameron, M J Harvey, D E Onions
British Journal of Cancer|January 1, 1997
Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?G Webster, D E Onions, J C Neil, et al.
Journal of Virology|September 18, 2001
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic miceE W Baxter, K Blyth, E R Cameron, et al.
Oncogene|December 22, 1999
A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with mycF Vaillant, K Blyth, A Terry, et al.
Oncogene|March 4, 2000
Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER miceK Blyth, M Stewart, M Bell, et al.
The Journal of Pathology|January 30, 1999
Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expressionA P Hall, J Irvine, K Blyth, et al.
Journal of Virology|April 1, 1996
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?E W Baxter, K Blyth, L A Donehower, et al.
Oncogene|April 21, 2001
Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral taggingK Blyth, A Terry, N Mackay, et al.
Pageof 2